InChIKey	FABPRXSRWADJSP-MEDUHNTESA-N
Compound Name	Moxifloxacin
Canonical SMILES	COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	6.38
Source	ChEMBL

DrugBank ID	DB00218
Drug Name	Moxifloxacin
CAS Number	151096-09-2
Groups	approved investigational
ATC Codes	S01AE07 J01MA14
Description	Moxifloxacin is a synthetic fluoroquinolone antibiotic agent. Bayer AG developed the drug (initially called BAY 12-8039) and it is marketed worldwide (as the hydrochloride) under the brand name Avelox (in some countries also Avalox) for oral treatment.

---

Categories: 4-Quinolones Anti-Bacterial Agents Anti-Infective Agents Antibacterials for Systemic Use Antiinfectives for Systemic Use Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (moderate) Cytochrome P-450 Enzyme Inhibitors Enzyme Inhibitors Fluoroquinolone Antibacterial Fluoroquinolones Heterocyclic Compounds, Fused-Ring Moderate Risk QTc-Prolonging Agents Ophthalmologicals QTc Prolonging Agents Quinolines Quinolone Antimicrobial Quinolones Sensory Organs Topoisomerase II Inhibitors Topoisomerase Inhibitors

---

Cross-references: BindingDB: 50366824 ChEBI: 63611 CHEMBL32 ChemSpider: 134802 Drugs Product Database (DPD): 12034 C07663 D08237 PDB: MFX PharmGKB: PA450555 PubChem:152946 PubChem:46508509 RxCUI: 139462 Therapeutic Targets Database: DAP000158 Wikipedia: Moxifloxacin ZINC: ZINC000003826253